The National Academies of Sciences, Engineering, and Medicine will establish an ad hoc committee to assess the use of the social constructs of race and ethnicity in biomedical research. The study will ...

Interrupted sleep, dwindling energy, diminishing libido and a vanishing metabolism. For many, these symptoms read like a script handed to men and women entering their 30s. And so many have come to ...

SAN JOSE, CA, UNITED STATES, January 6, 2026 /EINPresswire.com/ — — Biomed Industries, Inc. (“Biomed”), a clinical-stage biopharmaceutical company developing ...

Bristol Myers Squibb has become the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour BioMed for a multiyear research deal. The new pact will see the companies ...

Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, has announced a multi-year, global strategic ...

Introduction: Successful synchronized direct current cardioversion (DCCV) requires adequate current delivery to the heart. However, adequate current for successful DCCV is not yet established.

The information above is compiled from the publicly available data on the MCA website. To confirm any details or get the latest status, please consult the official Ministry of Corporate Affairs (MCA) ...

CALGARY, Alberta--(BUSINESS WIRE)--Fluid Biomed Inc. (“Fluid Biomed”), a medical device company dedicated to advancing neurovascular innovation, today announced the appointment of John Kilcoyne as ...

This single-center, ambispective cohort included patients undergoing one-stop procedures [LAAO combined with radiofrequency catheter ablation (RFCA)], where LAAO was performed first. DCCV was ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min BioMed alleges that the biotech ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company — a cross between ...